Trial Profile
A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan(CKD-828) Versus S-Amlodipine Monotherapy in Patients With Stage 2 Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Levamlodipine
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Chong Kun Dang
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea).
- 26 Jul 2012 Status changed from not yet recruiting to recruiting as reported by Korean Clinical Trials Register record.